PODN,也称为podocan,是一种编码蛋白质的基因,该蛋白质属于硫酸软骨素蛋白多糖家族。PODN在多种组织中表达,包括心脏、肺、肾和骨骼肌等,并在细胞外基质中发挥重要作用。PODN的蛋白质产物与细胞外基质的形成和维持密切相关,参与细胞黏附、迁移和信号传导等过程。
PODN基因在多种疾病的发生发展中发挥重要作用。例如,PODN基因的表达异常与骨肉瘤的发生发展密切相关。研究发现,PODN基因的表达水平在骨肉瘤组织中显著上调,且与患者的预后不良相关。此外,PODN基因的表达水平还与免疫浸润相关,表明PODN可能参与骨肉瘤的免疫调节过程[1]。
PODN基因的表达还受到多种因素的调控。例如,研究发现,高压水压条件下,miR-3180-5p的表达上调,而PODN的表达下调,从而促进人膀胱平滑肌细胞的增殖[2]。此外,PODN基因的表达还受到DNA甲基化的调控。研究发现,PODN基因启动子区域的DNA甲基化水平在胃癌组织中显著上调,且与患者的预后不良相关[3]。此外,PODN基因的表达还与TGF-β信号通路相关,该通路在卵巢癌的发生发展中发挥重要作用[4]。
此外,PODN基因的表达还与多种疾病的预后相关。例如,PODN基因的表达水平在肝细胞癌组织中显著上调,且与患者的预后不良相关[5]。此外,PODN基因的表达还与心脏扩张症的发病机制相关[6]。此外,PODN基因的表达还与头颈鳞状细胞癌的发生发展相关[7]。
综上所述,PODN基因在多种疾病的发生发展中发挥重要作用,包括骨肉瘤、膀胱平滑肌细胞增殖、胃癌、卵巢癌、肝细胞癌和心脏扩张症等。PODN基因的表达受到多种因素的调控,包括miRNA、DNA甲基化和TGF-β信号通路等。PODN基因的表达还与多种疾病的预后相关。因此,PODN基因的研究有助于深入理解疾病的发病机制和预后预测,为疾病的治疗和预防提供新的思路和策略。
参考文献:
1. Yao, Feng, Zhu, Zhao Feng, Wen, Jun, Zhen, Yun Fang, Wang, Xiao Dong. 2021. PODN is a prognostic biomarker and correlated with immune infiltrates in osteosarcoma. In Cancer cell international, 21, 381. doi:10.1186/s12935-021-02086-5. https://pubmed.ncbi.nlm.nih.gov/34273970/
2. Sun, Yi, Luo, De-Yi, Zhu, Yu-Chun, Shen, Hong, Wang, Kun-Jie. 2016. MiR 3180-5p promotes proliferation in human bladder smooth muscle cell by targeting PODN under hydrodynamic pressure. In Scientific reports, 6, 33042. doi:10.1038/srep33042. https://pubmed.ncbi.nlm.nih.gov/27608612/
3. Bai, Yi, Wei, Chunlian, Zhong, Yuxin, Wang, Xi, Zhao, Haitao. 2020. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes. In International journal of biological sciences, 16, 1153-1165. doi:10.7150/ijbs.41587. https://pubmed.ncbi.nlm.nih.gov/32174791/
4. Zhang, Xiaoxue, Han, Liping, Zhang, Huimin, Niu, Yameng, Liang, Ruopeng. 2023. Identification of potential key genes of TGF-beta signaling associated with the immune response and prognosis of ovarian cancer based on bioinformatics analysis. In Heliyon, 9, e19208. doi:10.1016/j.heliyon.2023.e19208. https://pubmed.ncbi.nlm.nih.gov/37664697/
5. Si, Tao, Ning, Xuejian, Chen, Haihui, Yang, Liu, Yi, Ping. . ANTXR1 as a potential prognostic biomarker for hepatitis B virus-related hepatocellular carcinoma identified by a weighted gene correlation network analysis. In Journal of gastrointestinal oncology, 12, 3079-3092. doi:10.21037/jgo-21-764. https://pubmed.ncbi.nlm.nih.gov/35070431/
6. Yu, Wei, Li, Lingjiao, Tan, Xingling, Yin, Chengliang, Cao, Junyi. 2023. Development and validation of risk prediction and neural network models for dilated cardiomyopathy based on WGCNA. In Frontiers in medicine, 10, 1239056. doi:10.3389/fmed.2023.1239056. https://pubmed.ncbi.nlm.nih.gov/37869159/
7. Wu, Zeng-Hong, Li, Cheng, Zhang, You-Jing, Zhou, Wen. 2022. Identification of a Cancer Stem Cells Signature of Head and Neck Squamous Cell Carcinoma. In Frontiers in genetics, 13, 814777. doi:10.3389/fgene.2022.814777. https://pubmed.ncbi.nlm.nih.gov/35646104/